Marco Schäferhoff, P., Armand Zimmerman, M., Mohamed M Diab, M., Wenhui Mao, P., Vipul Chowdhary, M., Davinder Gill, P., . . . Gavin Yamey, P. (2022). Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: A modelling study of the benefits and costs of investment in three middle-income countries. Elsevier.
Chicago Style (17th ed.) CitationMarco Schäferhoff, PhD, et al. Investing in Late-stage Clinical Trials and Manufacturing of Product Candidates for Five Major Infectious Diseases: A Modelling Study of the Benefits and Costs of Investment in Three Middle-income Countries. Elsevier, 2022.
MLA (9th ed.) CitationMarco Schäferhoff, PhD, et al. Investing in Late-stage Clinical Trials and Manufacturing of Product Candidates for Five Major Infectious Diseases: A Modelling Study of the Benefits and Costs of Investment in Three Middle-income Countries. Elsevier, 2022.